Thyroid incidentalomas in association with low-dose computed tomography in the National Lung Screening Trial.
Advances in cancer screening methods have opened avenues for incidental findings and cancer overdiagnosis. We performed a secondary analysis of the National Lung Screening Trial (enrollment from 2002-2004), a randomized controlled trial comparing low-dose computed tomography (LDCT, n=26,722) to chest radiography (CXR, n=26,732) for lung cancer detection, to examine incidental findings related to thyroid cancer (ThCa). Three screening rounds were included, and median follow-up was 6.6 and 6.5 years for LDCT and CXR, respectively. Radiologists reported lung and non-lung-related abnormalities. In the LDCT arm, 5.7%, 4.7%, and 4.5% of participants had abnormalities above the diaphragm (AADs) detected at baseline, Year 1, and Year 2, respectively, compared to 2.3%, 1.5%, and 1.3% in the CXR arm. In the LDCT arm, 205 AADs (7.0%) were thyroid-related. Overall, 60 ThCas were reported, 35 in the LDCT and 25 in the CXR arm (p=0.2). In the LDCT arm, participants with a prior AAD had a 7.8-fold increased risk (95% CI: 4.0, 15.1) of ThCa compared to those without an AAD. Early and persistent excess of ThCas diagnosed earlier in the LDCT arm suggests overdiagnosis. The use of sensitive screening modalities for early detection of lung cancer may result in the discovery of thyroid incidentalomas.